• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BALT USA BARRICADE COIL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BALT USA BARRICADE COIL SYSTEM Back to Search Results
Model Number 900107
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/19/2021
Event Type  malfunction  
Event Description
It was reported that: "at the moment of opening the box containing barricade coil 2x4 the bag was apart from the sheath which usually contains the coil, meaning that the coil wasn't sterile.However, the product was removed from its case because it was an emergency and there were no more of these products at that time.When the coil was introduced intro the patient, the x-rays showed that there was no coil, only the carrier wire was present.As one usually advances the coil until it is seen in the x-rays, as there was none, it was pushed and the carrier wire collided with the aneurysm but it didn't rupture it." incident report form received for this complaint indicated no patient injury was sustained.
 
Manufacturer Narrative
Balt usa reference # (b)(4).Note: this complaint file is being reported late as part of a corrective action following an fda inspection.After a review of historical complaint files, it was determined that for this complaint the device failed to meet its performance specifications according to the initial claim submitted by the user.For these complaints, the potential harm did not lead to a serious injury or death, however the performance specification which was failed to be met for these complaints could have led to a serious injury or death based on the initial information that was reported to balt.The returned device was inspected in our quality laboratory.During our analysis: - we noted that the returned device pouch was opened and found no abnormalities along the pouch seal; - we observed no puncture holes throughout the pouch; - we observed that the proximal end of the implant still found connected to the delivery pusher; - we observed the implant coil to be broken off of the proximal end of the implant less than 1mm from the glue bond.Root cause of the reported issues endured by the coil system can not be definitively determined.Upon return of this device, it was observed that the pouch was already opened.Further investigation showed that there were no visible abnormalities along the pouch seal, indicating proper closure of the aforementioned pouch.Moreover, no puncture holes were seen throughout the pouch.Despite sterility issue claims, the device was used which contradicts the ifu statement "the bcs is intended for single use only.Do not resterilize and/or reuse the device.Reuse of the device may result in re-infection or cross-infection.After use, dispose in accordance with hospital, administrative and/or local government policy.Do not use if the packaging is breached or damaged." it was then noted that "when the coil was introduced intro the patient, the x-rays showed that there was no coil, only the carrier wire was present.As one usually advances the coil until it is seen in the x-rays, as there was none, it was pushed and the carrier wire collided with the aneurysm but it didn't rupture it." additional investigation showed that the proximal end of the implant was still found connected to the delivery pusher, indicating that a coil was previously attached to the pusher system.Per lhr, 100% inspection was conducted, with qc final inspection and pouch inspection approval.It is unknown how or when the implant coil separated from its respective pusher system.It is possible that the implant became fractured from the delivery pusher while the coil system was being removed from the pouch, but this cannot be confirmed.Review of the lot history records did not reveal any in-process or lot-specific issue that could account for the observation.No additional complaints against lot number f200100198 has been made for the same issue.Comprehensive analysis of this failure mode has remained subject to monitoring for any unacceptable increase in trend.The submission of this report or related information to the fda, and its release by fda, does not reflect a conclusion by the party submitting this report of the fda that the report or related information is an admission that the manufacturer, their employees, or the device caused or contributed to the reportable event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARRICADE COIL SYSTEM
Type of Device
BARRICADE
Manufacturer (Section D)
BALT USA
29 parker
irvine CA 92618
Manufacturer Contact
david vu
29 parker
irvine, CA 92618
9497881443
MDR Report Key17572780
MDR Text Key321640412
Report Number3014162263-2023-00031
Device Sequence Number1
Product Code HCG
UDI-Device Identifier00818053021060
UDI-Public(01)00818053021060(11)200131(17)250131(10)F200100198
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
K151760
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/18/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number900107
Device Lot NumberF200100198
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/11/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/25/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/31/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-